Lawsuits attack medical trials; as claims arise, some fear tests will lose public support

Article Abstract:

Litigation concerning the wrongful deaths of patients in clinical trials and the novel theories used to back up some of these claims is discussed. Jesse Gelsinger, a teenager who died in a gene therapy experiment at the University of Pennsylvania, is the one most covered by the media. The lawyer representing Gelsinger's family claims a violation of the 14th Amendment.

Clinical trials, Gene therapy, Human experimentation in medicine, Human medical experimentation

---

Problems galore

Article Abstract:

Linda M Mitchell, vice president and general counsel of America West Airlines Inc, is profiled. A downturn in business travel caused the airline severe financial problems even before September 11, and like other airlines, will be forced to file for bankruptcy protection unless it receives federal aid.

America West Airlines Inc., Mitchell, Linda M.

---

Oil and patents

Article Abstract:

Eric Grimshaw, the vice president, general counsel and secretary of the Syntroleum Corp, an energy technology company, is profiled. The company had a market capitalization of $200 mil when it went public in 1998 and expects that 2003 will mark its first positive cash flow.

Management, Officials and employees, Syntroleum Corp., SYNM, Grimshaw, Eric

Similar abstracts:

• Abstracts: Largest circuit is still the maverick; reputation as liberal remains, despite some moves to center. P&G peddles a private patent court
• Abstracts: 'Festo' opens the door; case sharply limits doctrine of equivalents; designing around patents will now succeed more
• Abstracts: Critical conditions; goal to reduce medical errors is fraught with difficulties. Trafficking in color; evidence challenged in race-based cop stops
• Abstracts: 'Tasini' case may set back free-lancers, publishers; to avoid expense, publishers may remove existing works from online publications
• Abstracts: Second wind; tobacco battles shift back to trial courts after justices spare the industry from FDA regulation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.